Is teicoplanin a complementary treatment option for COVID-19? The question remains
Giancarlo Ceccarelli, Francesco Alessandri, Gabriella d’Ettorre, Cristian Borrazzo, Ornella Spagnolello, Alessandra Oliva, Franco Ruberto, Claudio Maria Mastroianni, Francesco Pugliese, Mario Venditti
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Teicoplanin2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineIntensive care medicineVirologyInternal medicineVancomycinInfectious disease (medical specialty)BiologyDiseaseStaphylococcus aureusGeneticsBacteriaOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19